Agenus Inc.

11/07/2024 | Press release | Distributed by Public on 11/07/2024 12:01

Preclinical Dose Pharmacokinetic Efficacy Modeling of Botensilimab Using a Mouse Surrogate of the Fc Enhanced Anti CTLA 4 Antibody